Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Optic Neuritis in a Patient with Bickerstaff's Brainstem Encephalitis.
Role of Sonic Hedgehog Signaling in Oligodendrocyte Differentiation.
PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier.
Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and cyclophosphamide among patients with neuromyelitis optica spectrum disorder: A prospective cohort study.
Cholinergic system and neuroinflammation: Implication in multiple sclerosis.
Dimethyl fumarate alters microglia phenotype and protects neurons against proinflammatory toxic microenvironments.
Challenges in pediatric chronic inflammatory demyelinating polyneuropathy.
2'-5' oligoadenylate synthetase-like 1 (OASL1) deficiency suppresses central nervous system damage in a murine MOG-induced multiple sclerosis model.
Neuromuscular Electrical Stimulation Can Improve Walking Endurance In Individuals With Multiple Sclerosis: 2573 Board #96 June 3, 9: 30 AM - 11: 00 AM.
Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.
Nuclear factor erythroid 2-related factor 2 is a critical target for the treatment of glucocorticoid-resistant lupus nephritis.
Addition of a general surgeon without addition of appropriate support is inadequate to improve outcomes of trauma patients in a rural setting: a cohort study of 1962 consecutive patients.
Microbiomic and Posttranslational Modifications as Preludes to Autoimmune Diseases.
Relationship between the corpus callosum and neurocognitive disabilities in children with NF-1: diffusion tensor imaging features.
Complex coacervation for the development of composite edible films based on LM pectin and sodium caseinate.
CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.
The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6.
Clinical Application of Autologous Adipose Stem Cells in Patients with Multiple Sclerosis: Preliminary Results.
Extracranial Head and Neck Schwannomas: Our Experience.
Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy.
Activity-dependent calcium signalling in oligodendrocyte generation.
A decade of natalizumab and PML: Has there been a tacit transfer of risk acceptance?
Transcellular spreading of huntingtin aggregates in the Drosophila brain.
Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.
Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery.

Pages